Serum leptin in children and young adults with inflammatory bowel disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 26, Issue 5, 1998, Pages 500-505

  Hoppin, Alison G ^a,b   Kaplan, Lee M ^a,b   Zurakowski, David ^c   Leichtner, Alan M ^a   Bousvaros, Athos ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Crohn's disease; Growth failure; Leptin; Malnutrition; Ulcerative colitis

Indexed keywords

LEPTIN;

ADOLESCENT; ADULT; ANOREXIA; ARTICLE; BODY MASS; CHILD; CROHN DISEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENTERITIS; FEMALE; GROWTH DISORDER; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; LEPTIN; MALE; PROSPECTIVE STUDIES; PROTEINS;

EID: 0031897150     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-199805000-00003     Document Type: Article

References (37)

1. Kanof ME, Lake AM, Bayless TM. Decreased height velocity in children and adolescents before the diagnosis of Crohn's disease. Gastroenterology 1988;95:1523-7.
2. Kirschner BS. Growth and development in chronic inflammatory bowel disease. Acta Paediatr Scand 1990;366:98-104.
3. Kirschner BS. Ulcerative colitis and Crohn's disease in children. Diagnosis and management. Gastroenterol Clin North Am 1995; 24:99-117.
4. Motil KJ, Grand RJ, Maletskos CJ, Young VR. The effect of disease, drug, and diet on whole body protein metabolism in adolescents with Crohn disease and growth failure. J Pediatr 1982; 101:345-51.
5. Kirschner BS, Sutton MM. Somatomedin-C levels in growth-impaired children and adolescents with chronic inflammatory bowel disease. Gastroenterology 1986;91:830-6.
6. Thomas AG, Holly JM, Taylor F, Miller vs. Insulin like growth factor-I, insulin like growth factor binding protein-1, and insulin in childhood Crohn's disease. Gut 1993;34:944-7.
7. Barot LR, Rombeau JL, Steinberg JJ, Crosby LO, Feurer ID, Mullen JL. Energy expenditure in patients with inflammatory bowel disease. Arch Surg 1981;116:460-2.
8. Nassif A, Longo WE, Mazuski JE, Vernava AM, Kaminski DL. Role of cytokines and platelet-activating factor in inflammatory bowel disease. Implications for therapy. Dis Colon Rectum 1996; 39:217-23.
9. Braegger CP. Immunopathogenesis of chronic inflammatory bowel disease. Acta Paediatr Suppl 1994;83:18-21.
10. Bross DA, Leichtner AM, Zurakowski D, Law T, Bousvaros A. Elevation of serum interleukin-6 but not serum-soluble interleukin-2 receptor in children with Crohn's disease. J Pediatr Gastroenterol Nutr 1996;23:164-71.
11. Mahida YR, Kurlac L, Gallagher A, Hawkey CJ. High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis. Gut 1991;32:1531-4.
12. Sarraf P, Frederich RC, Turner EM, et al. Multiple cytokines and acute inflammation raise mouse leptin levels: Potential role in inflammatory anorexia. J Exp Med 1997;185:171-5.
13. Tracey KJ, Wei H, Manogue KR, et al. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J Exp Med 1988;167:1211-27.
14. Grunfeld C, Pang M, Shimizu L, Shigenaga JK, Jensen P, Feingold KR. Resting energy expenditure, caloric intake, and short-term weight change in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Am J Clin Nutr 1992;55: 455-60.
15. Balkwill F, Osborne R, Burke F, et al. Evidence for tumour necrosis factor/cachetin production in cancer. Lancet 1987;2:1229-32.
16. Hyams JS, Treem WR, Eddy E, Wyzga N, Moore RE. Tumor necrosis factor-alpha is not elevated in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1991;12:233-6.
17. Murch SH, Lamkin VA, Savage MO, Walker-Smith JA, MacDonald TT. Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease. Gut 1991;32: 913-7.
18. Lee GH, Proenca R, Montez JM, et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996;379:632-5.
19. Maffei M, Halaas J, Ravussin E, et al. Leptin levels in human and rodent - measurement of plasma leptin and ob rna in obese and weight-reduced subjects. Nat Med 1995;1:1155-61.
20. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS. Leptin levels reflect body lipid content in mice - evidence for diet-induced resistance to leptin action. Nat Med 1995;1: 1311-4.
21. Pelleymounter MA, Cullen MJ, Baker MB, et al. Effects of the obese gene product on body weight regulation in ob ob mice. Science 1995;269:540-3.
22. Considine RV, Considine EL, Williams CJ, Hyde TM, Caro JF. The hypothalamic leptin receptor in humans - identification of incidental sequence polymorphisms and absence of the db/db mouse and fa fa rat mutations. Diabetes 1996;45:992-4.
23. Grunfeld C, Zhao C, Fuller J, et al. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters - a role for leptin in the anorexia of infection. J Clin Invest 1996;97:2152-7.
24. Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 1991;12:439-47.
25. Kozarek RA, Patterson DJ, Gelfand MD, Botoman VA, Ball TJ, Wilske KR. Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease. Ann Intern Med 1989;110:353-6.
26. Ma ZM, Gingerich RL, Santiago JV, Klein S, Smith CH, Landt M. Radioimmunoassay of leptin in human plasma. Clin Chem 1996; 42:942-6.
27. Shapiro SS, Wilk MB. An analysis of variance test for normality (complete samples). Biometrika 1965;52:591-611.
28. Bland JM, Altman DG. Multiple significance tests: The Bonferroni method. BMJ 1995;310:170.
29. Zar JH. Biostatistical Analysis. Upper Saddle River, NJ: Prentice-Hall, 1996:413-8.
30. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-5.
31. De Vos P, Saladin R, Auwerx J, Staels B. Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake. J Biol Chem 1995;270:15958-61.
32. Caprio S, Tamborlane WV, Silver D, et al. Hyperleptinemia: An early sign of juvenile obesity. Relations to body fat depots and insulin concentrations. Am J Physiol 1996;271:E626-30.
33. Must A, Dallal GE, Dietz WH. Reference data for obesity: 85th and 95th percentiles of body mass index (wt ht2) and triceps skin-fold thickness. Am J Clin Nutr 1991;53:839-46.
34. Grunfeld C, Pang M, Shigenaga JK, et al. Serum leptin levels in the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1996;81:4342-6.
35. Yarasheski KE, Zachwieja JJ, Horgan MM, Powderly WG, Santiago JV, Landt M. Serum leptin concentrations in human immunodeficiency virus-infected men with low adiposity. Metabolism 1997;46:303-5.
36. Nagy TR, Gower BA, Trowbridge CA, Dezenberg C, Shewchuk RM, Goran MI. Effects of gender, ethnicity, body composition, and fat distribution on serum leptin concentrations in children. J Clin Endocrinol Metab 1997;82:2148-52.
37. Rosenbaum M, Nicolson M, Hirsch J, et al. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab 1996;81:3424-7.